Mega Biosciences Private Limited
About Mega Biosciences Private Limited
Data last updated:
Mega Biosciences Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 12 February 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74140DL2011PTC213894. Its GSTIN is 07AAHCM0446J1ZG (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ajay Chaudhary and Renu Chaudhary.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 85 Gram Sabha Sewak Park Near Dwarka Mor Metro Station Uttam Nag, Ar, New Delhi, Delhi, India – 110059.
As per the financials filed for FY 2024, the company reported a revenue of ₹31.95 Lakh, a decline of 24% compared to the previous year. For the same year it recorded a net profit of ₹1.06 Lakh (net margin 3.3%) and EBITDA of ₹1.47 Lakh (EBITDA margin 4.6%). Revenue has declined at a compounded annual rate (CAGR) of 4% over three years and 11% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Mega Biosciences Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressA – 85 Gram Sabha Sewak Park Near Dwarka Mor Metro Station Uttam Nag, Ar, New Delhi, Delhi, India – 110059
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Mega Biosciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Mega Biosciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Mega Biosciences Private Limited, buy the company report.
Financials of Mega Biosciences Private Limited
FY 2025 filings availableMega Biosciences Private Limited reported revenue of ₹31.95 Lakh (down 24% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 11% over five years, including a 24% fall in the latest year. EBITDA fell 27% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.47 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.06 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.6% | ||||
| Net Profit Margin | 3.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mega Biosciences Private Limited, buy the company report.
Board of directors of Mega Biosciences Private Limited
Mega Biosciences has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ajay Chaudhary | Director | 12 Feb 2011 | 15 Years 8 Months | Current |
| Renu Chaudhary | Director | 12 Feb 2011 | 15 Years 8 Months | Current |
Peer comparison
Mega Biosciences Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Biosciences, Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shankhpani Healthcare Private Limited | ₹32.13 Lakh (FY 2024) | -11.0% | Varanasi, Uttar Pradesh, India | |||
| Mebo Pharmaceutical (India) Private Limited | ₹32.07 Lakh (FY 2025) | -9.0% | New Delhi, Delhi, India | |||
| Alyssum Pharma Private Limited | ₹31.99 Lakh (FY 2024) | -1.0% | Bhopal, Madhya Pradesh, India | |||
| Mega Biosciences Private Limitedthis company | ₹31.95 Lakh (FY 2024) | ₹1.06 Lakh | 3.3% | -24.0% | New Delhi, Delhi, India | |
| Taparia Tex Fab Private Limited | ₹31.94 Lakh (FY 2025) | 12.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Mega Biosciences Private Limited, buy the company report.
Auditor
Mega Biosciences Private Limited is audited by VIRENDER GUPTA & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VIRENDER GUPTA & ASSOCIATES | FY 2021 | 026919N |
Shareholding
The shareholding of Mega Biosciences Private Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Mega Biosciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Mega Biosciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mega Biosciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Mega Biosciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAHCM0446J1ZG | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Mega Biosciences Private Limited, buy the company report.
Recent activity
Mega Biosciences Private Limited has 2 board changes on record since 2011: 2 appointments. The latest: Ajay Chaudhary was appointed as Director on 12 Feb 2011.
Frequently asked questions
Mega Biosciences is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 12 February 2011 (15+ years old) and is registered under CIN U74140DL2011PTC213894.
Mega Biosciences has 2 current directors:
- Ajay Chaudhary - Director
- Renu Chaudhary - Director
The latest financial statements of Mega Biosciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Mega Biosciences is 07AAHCM0446J1ZG, registered in Delhi.
The CIN (Corporate Identification Number) of Mega Biosciences is U74140DL2011PTC213894. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mega Biosciences was incorporated on 12 February 2011, making it 15+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Mega Biosciences by revenue are Shankhpani Healthcare Private Limited, Mebo Pharmaceutical (India) Private Limited, Alyssum Pharma Private Limited, Taparia Tex Fab Private Limited, all in the Pharma industry (Biosciences, Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Ajay Chaudhary was appointed as Director on 12 Feb 2011. Renu Chaudhary was appointed as Director on 12 Feb 2011.
The registered office of Mega Biosciences is at A – 85 Gram Sabha Sewak Park Near Dwarka Mor Metro Station Uttam Nag, Ar, New Delhi, Delhi, India – 110059.
Mega Biosciences operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Mega Biosciences is compliant as of 08 August 2026. The company is actively filing with the Registrar of Companies.